Close Menu

NEW YORK (360Dx) – Veterinary drug company Zomedica Pharmaceuticals said today that it has entered into a research collaboration with liquid biopsy firm Celsee Diagnostics. Under the agreement, the companies plan to test the feasibility of Celsee’s circulating tumor cell detection and analysis technology for diagnosing cancer in dogs.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.